All good points of course and from what  I read and follow it appears are timing is off. Certainly not hoping for a more worrisome variant but it looks like omicron in itself is helping immunity. I am in this for BetonMace 11 and think we should get on with it and secure financing as mentioned by DM in his last presentation. Certainly going the covid route is only helpful towards that end. The priority should be BM2. Possibly Apabetalone may also play a role in covid or future variants eventually who knows but they have a BTD for BM2 not Covid.

The take away here is it will take a lot of money to fund that Rvx has not secured yet. At least that they haven't shared or confirmed so far.